ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 208 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,000 | +600.0% | 435 | +559.1% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 66 | -40.0% | 0.00% | – |
| Q1 2022 | $2,000 | -50.0% | 110 | -41.8% | 0.00% | – |
| Q4 2021 | $4,000 | +100.0% | 189 | +33.1% | 0.00% | – |
| Q3 2021 | $2,000 | -85.7% | 142 | -74.6% | 0.00% | -100.0% |
| Q2 2021 | $14,000 | +366.7% | 560 | +321.1% | 0.00% | – |
| Q1 2021 | $3,000 | -50.0% | 133 | +25.5% | 0.00% | -100.0% |
| Q4 2020 | $6,000 | +200.0% | 106 | +158.5% | 0.00% | – |
| Q3 2020 | $2,000 | -95.1% | 41 | -95.8% | 0.00% | -100.0% |
| Q1 2020 | $41,000 | -14.6% | 968 | -15.8% | 0.01% | +16.7% |
| Q4 2019 | $48,000 | +41.2% | 1,149 | +18.7% | 0.01% | +20.0% |
| Q3 2019 | $34,000 | +36.0% | 968 | 0.0% | 0.01% | +25.0% |
| Q2 2019 | $25,000 | -62.7% | 968 | -58.7% | 0.00% | -88.2% |
| Q4 2016 | $67,000 | -17.3% | 2,345 | -9.1% | 0.03% | -35.8% |
| Q3 2016 | $81,000 | +1057.1% | 2,581 | +1022.2% | 0.05% | +960.0% |
| Q2 2016 | $7,000 | +16.7% | 230 | +28.5% | 0.01% | +25.0% |
| Q4 2015 | $6,000 | – | 179 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
| GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
| Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
| Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
| Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
| Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
| Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
| PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |